Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,356 | 21,448 | 20,618 | 22,657 | 1,579 |
| TOTAL | $17,737 | $22,282 | $21,509 | $23,425 | $2,279 |
| Non-Current Assets | |||||
| PPE Net | 294 | 141 | N/A | N/A | N/A |
| Intangibles | 8,512 | 47,336 | 2,186 | 2,362 | 1,818 |
| Other Non-Current Assets | 176 | 0 | 0 | 0 | 0 |
| TOTAL | $8,982 | $47,476 | $2,186 | $2,362 | $1,818 |
| Total Assets | $26,719 | $69,758 | $23,695 | $25,787 | $4,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 149 | N/A | N/A |
| Accounts payable and accrued liabilities | 683 | 2,163 | 1,019 | 627 | 681 |
| Other current liabilities | 1,946 | N/A | N/A | N/A | N/A |
| TOTAL | $2,737 | $2,163 | $1,168 | $627 | $681 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 69 | 3,166 | 3,709 | 6,168 | 0 |
| TOTAL | $1,676 | $12,228 | $3,709 | $6,168 | $N/A |
| Total Liabilities | $4,413 | $14,391 | $4,876 | $6,795 | $681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6 | 3 | 2 | 2 | 2 |
| Common Shares | 7 | 314 | 214 | 195 | 101 |
| Retained earnings | -60,737 | -18,631 | -15,919 | -15,010 | -11,760 |
| Other shareholders' equity | -31 | -185 | -179 | -146 | -181 |
| TOTAL | $22,306 | $55,367 | $18,819 | $18,992 | $3,416 |
| Total Liabilities And Equity | $26,719 | $69,758 | $23,695 | $25,787 | $4,097 |